Abstract
Clinical heterogeneity in the symptom trajectories of attention deficit hyperactivity disorder (ADHD) is well documented, but their neurodevelopmental mechanisms remain unclear. We used a longitudinal cohort of adolescents (ABCD; n = 7,436) to show that persistent, remitting and emergent ADHD symptom trajectories correlated with persistent, improving and worsening behavioral changes, respectively. Each trajectory had distinct brain signatures: faster cortical thinning (persistence), slower thinning (emergence) and faster subcortical expansion (remission). Slower cortical thinning in the right posterior cingulate was associated with inattention symptom increase, whereas faster hippocampal expansion was associated with inattention symptom decrease. These signatures enhance ADHD symptom prediction at age 13 and generalize to young adults (age 23) in the IMAGEN cohort. The hippocampal signature for remitting symptoms was replicated in IMAGEN and two clinical cohorts (ADHD-200 and ADHD-1000). Given that baseline ADHD medication use was not significantly associated with the remitting trajectory, our findings suggest that current treatments may not facilitate sustained remission, highlighting the potential for new interventions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$79.00 per year
only $6.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
Data availability
Data are publicly released on an annual basis through the NDA (https://nda.nih.gov/abcd). The ABCD Study data are openly available to qualified researchers for free. Access can be requested at https://nda.nih.gov/abcd/request-access. The ABCD data used in this report came from the ABCD Study at https://doi.org/10.15154/z563-zd24. The IMAGEN study data are available upon application: https://www.imagen-project.org/. ADHD-200 data are available from a dedicated database (http://fcon_1000.projects.nitrc.org/indi/adhd200). ADHD-1000 data were downloaded from the https://nda.nih.gov/study.html?id=1938. Summary statistics of genome-wide association studies for ADHD are publicly available and can be downloaded from https://pgc.unc.edu/for-researchers/download-results/. The transcriptomic data were downloaded from the AHBA (https://human.brain-map.org/). Due to participant privacy and institutional data-use restrictions, the ADHD-Shanghai dataset cannot be publicly shared. The data are available from the corresponding author upon reasonable request and subject to institutional approval. Source data are provided with this paper.
Code availability
Code for the replication of analyses conducted in the paper can be retrieved from https://github.com/DanTouHaHa/Neurodevelopmental-Correlates-of-ADHD-Symptom-Trajectories. Brain visualizations were generated by the authors using the ENIGMA Toolbox66 (https://enigma-toolbox.readthedocs.io/).
References
Cortese, S. et al. Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study. Mol. Psychiatry 28, 4823–4830 (2023).
Faraone, S. V. et al. Attention-deficit/hyperactivity disorder. Nat. Rev. Dis. Prim. 10, 11 (2024).
Norman, L. J. et al. Longitudinal trajectories of childhood and adolescent attention deficit hyperactivity disorder diagnoses in three cohorts. EClinicalMedicine 60, 102021 (2023).
Shaw, P. & Sudre, G. Adolescent attention-deficit/hyperactivity disorder: understanding teenage symptom trajectories. Biol. Psychiatry 89, 152–161 (2021).
Shaw, P. et al. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder. Am. J. Psychiatry 166, 58–63 (2009).
Shaw, P. et al. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol. Psychiatry 74, 599–606 (2013).
Sudre, G. et al. Predicting the course of ADHD symptoms through the integration of childhood genomic, neural, and cognitive features. Mol. Psychiatry 26, 4046–4054 (2021).
Sibley, M. H. et al. Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. Am. J. Psychiatry 179, 142–151 (2022).
Shaw, P. et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc. Natl Acad. Sci. USA 104, 19649–19654 (2007).
Shaw, P. et al. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 63, 540–549 (2006).
Muetzel, R. L. et al. Tracking brain development and dimensional psychiatric symptoms in children: a longitudinal population-based neuroimaging study. Am. J. Psychiatry 175, 54–62 (2017).
Wang, Y. et al. The neural and genetic underpinnings of different developmental trajectories of attention-deficit/hyperactivity symptoms in children and adolescents. BMC Med. 22, 223 (2024).
Jung, T. & Wickrama, K. A. S. An introduction to latent class growth analysis and growth mixture modeling. Soc. Personal. Psychol. Compass 2, 302–317 (2008).
Guerrera, S. et al. Assessment of psychopathological comorbidities in children and adolescents with autism spectrum disorder using the child behavior checklist. Front. Psychiatry https://doi.org/10.3389/fpsyt.2019.00535 (2019).
Chen, J. W. et al. Best practice guidelines for propensity score methods in medical research: consideration on theory, implementation, and reporting. A review. Arthroscopy 38, 632–642 (2022).
Shaw, M. et al. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 10, 99 (2012).
Mechler, K., Banaschewski, T., Hohmann, S. & Häge, A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol. Ther. 230, 107940 (2022).
Baboli, R. et al. Distinct structural brain network properties in children with familial versus non-familial attention-deficit/hyperactivity disorder (ADHD). Cortex 179, 1–13 (2024).
Long, Y. et al. Distinct brain structural abnormalities in attention-deficit/hyperactivity disorder and substance use disorders: a comparative meta-analysis. Transl. Psychiatry 12, 368 (2022).
Hoogman, M. et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 4, 310–319 (2017).
Bahrami, S. et al. Distributed genetic architecture across the hippocampal formation implies common neuropathology across brain disorders. Nat. Commun. 13, 3436 (2022).
Noble, K. G. et al. Hippocampal volume varies with educational attainment across the life-span. Front. Hum. Neurosci. 6, 307 (2012).
Kandola, A., Hendrikse, J., Lucassen, P. J. & Yücel, M. Aerobic exercise as a tool to improve hippocampal plasticity and function in humans: practical implications for mental health treatment. Front. Hum. Neurosci. 10, 373 (2016).
Saccaro, L. F. et al. Limbic-sensorimotor tug of war for the hippocampus: dynamic functional connectivity as a transdiagnostic vulnerability marker in offspring of emotion dysregulation patients. Biol. Psychiatry Cogn. Neurosci. Neuroimaging https://doi.org/10.1016/j.bpsc.2025.03.007 (2025).
Russell, V. A. Neurobiology of animal models of attention-deficit hyperactivity disorder. J. Neurosci. Methods 161, 185–198 (2007).
Hilton, B. J., Griffin, J. M., Fawcett, J. W. & Bradke, F. Neuronal maturation and axon regeneration: unfixing circuitry to enable repair. Nat. Rev. Neurosci. 25, 649–667 (2024).
Anacker, C. & Hen, R. Adult hippocampal neurogenesis and cognitive flexibility—linking memory and mood. Nat. Rev. Neurosci. 18, 335–346 (2017).
Shen, C. et al. Neural correlates of the dual-pathway model for ADHD in adolescents. Am. J. Psychiatry 177, 844–854 (2020).
Shaw, P., Stringaris, A., Nigg, J. & Leibenluft, E. Emotion dysregulation in attention deficit hyperactivity disorder. Am. J. Psychiatry 171, 276–293 (2014).
Sakai, J. How synaptic pruning shapes neural wiring during development and, possibly, in disease. Proc. Natl Acad. Sci. USA 117, 16096–16099 (2020).
Demontis, D. et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat. Genet. 55, 198–208 (2023).
Contreras, D. et al. Methylphenidate restores behavioral and neuroplasticity impairments in the prenatal nicotine exposure mouse model of ADHD: evidence for involvement of AMPA receptor subunit composition and synaptic spine morphology in the hippocampus. Int. J. Mol. Sci. https://doi.org/10.3390/ijms23137099 (2022).
Ginsberg, Y., Quintero, J., Anand, E., Casillas, M. & Upadhyaya, H. P. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim. Care Companion CNS Disord. https://doi.org/10.4088/PCC.13r01600 (2014).
Isaac, V., Lopez, V. & Escobar, M. J. Can attention-deficit/hyperactivity disorder be considered a form of cerebellar dysfunction. Front. Neurosci. 19, 1453025 (2025).
Wang, Y. et al. Association of emotional and behavioral problems with the development of the substantia nigra, subthalamic nucleus, and red nucleus volumes and asymmetries from childhood to adolescence: a longitudinal cohort study. Transl. Psychiatry 14, 117 (2024).
Schumann, G. et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol. Psychiatry 15, 1128–1139 (2010).
Nigg, J. T. et al. The Oregon ADHD-1000: a new longitudinal data resource enriched for clinical cases and multiple levels of analysis. Dev. Cogn. Neurosci. 60, 101222 (2023).
DuPaul, G. J., Power, T. J., Anastopoulos, A. D. & Reid, R. ADHD Rating Scale—IV: Checklists, Norms, and Clinical Interpretation. (The Guilford Press, 1998).
Achenbach, T. M. Achenbach System of Empirically Based Assessment (ASEBA). In The Encyclopedia of Clinical Psychology (eds Cautin, R. L. & Lilienfeld, S. O.) 1–8 (Wiley-Blackwell, 2015); https://doi.org/10.1002/9781118625392.wbecp150
Nakamura, B. J., Ebesutani, C., Bernstein, A. & Chorpita, B. F. A psychometric analysis of the Child Behavior Checklist DSM-Oriented Scales. J. Psychopathol. Behav. Assess. 31, 178–189 (2009).
Bernanke, J. et al. Structural brain measures among children with and without ADHD in the Adolescent Brain and Cognitive Development Study cohort: a cross-sectional US population-based study. Lancet Psychiatry 9, 222–231 (2022).
Li, Q. et al. Cognitive predictors of mental health trajectories are mediated by inferior frontal and occipital development during adolescence. Mol. Psychiatry https://doi.org/10.1038/s41380-025-02912-6 (2025).
Bleck, T. P., Nowinski, C. J., Gershon, R. & Koroshetz, W. J. What is the NIH Toolbox, and what will it mean to neurology?. Neurology 80, 874–875 (2013).
Acker, W. J. I. J. O. M.-M. S. A computerized approach to psychological screening—The Bexley-Maudsley Automated Psychological Screening and the Bexley-Maudsley Category Sorting Test. Int. J. Man Mach. Stud. 17, 361–369 (1982).
Serrano-Ibáñez, E. R., Ramírez-Maestre, C., Esteve, R. & López-Martínez, A. E. The behavioural inhibition system, behavioural activation system and experiential avoidance as explanatory variables of comorbid chronic pain and posttraumatic stress symptoms. Eur. J. Psychotraumatol. 10, 1581013 (2019).
Mujahid, M. S., Diez Roux, A. V., Morenoff, J. D. & Raghunathan, T. Assessing the measurement properties of neighborhood scales: from psychometrics to ecometrics. Am. J. Epidemiol. 165, 858–867 (2007).
Sanford, K., Bingham, C. R. & Zucker, R. A. Validity issues with the Family Environment Scale: psychometric resolution and research application with alcoholic families. Psychol. Assess. 11, 315–325 (1999).
Arthur, M. W. et al. Measuring risk and protection in communities using the Communities That Care Youth Survey. Eval. Program Plann. 30, 197–211 (2007).
Gonzalez, R. et al. An update on the assessment of culture and environment in the ABCD Study: emerging literature and protocol updates over three measurement waves. Dev. Cogn. Neurosci. 52, 101021 (2021).
Goodman, R., Meltzer, H. & Bailey, V. The Strengths and Difficulties Questionnaire: a pilot study on the validity of the self-report version. Int. Rev. Psychiatry 15, 173–177 (2003).
Ferreira, V. R. et al. Sleep disturbance scale for children: translation, cultural adaptation, and validation. Sleep Med. 10, 457–463 (2009).
Bunford, N. et al. The Difficulties in Emotion Regulation Scale-Parent Report: a psychometric investigation examining adolescents with and without ADHD. Assessment 27, 921–940 (2020).
Hagler, D. J. et al. Image processing and analysis methods for the Adolescent Brain Cognitive Development Study. NeuroImage 202, 116091 (2019).
Fischl, B. FreeSurfer. NeuroImage 62, 774–781 (2012).
Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31, 968–980 (2006).
Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341–355 (2002).
Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391–399 (2012).
Arnatkevic̆iūtė, A., Fulcher, B. D. & Fornito, A. A practical guide to linking brain-wide gene expression and neuroimaging data. NeuroImage 189, 353–367 (2019).
Dukart, J. et al. JuSpace: a tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum. Brain Mapp. 42, 555–566 (2021).
Nigg, J. T. et al. Attention-deficit/hyperactivity disorder (ADHD) and being overweight/obesity: new data and meta-analysis. Clin. Psychol. Rev. 43, 67–79 (2016).
Zhao, C.-l. et al. Sex differences of signal complexity at resting-state functional magnetic resonance imaging and their associations with the estrogen-signaling pathway in the brain. Cogn. Neurodyn. https://doi.org/10.1007/s11571-023-09954-y (2023).
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353–D361 (2017).
Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).
Piñero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 45, D833–D839 (2016).
Koopmans, F. et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron 103, 217–234.e214 (2019).
Larivière, S. et al. The ENIGMA Toolbox: multiscale neural contextualization of multisite neuroimaging datasets. Nat. Methods 18, 698–700 (2021).
Acknowledgements
This study was partially supported by grants from the National Key Research and Development Program of China (number 2023YFE0109700) (Q. Luo), the National Natural Science Foundation of China (numbers 82272079 and 32441107) (Q. Luo) and the Program of Shanghai Academic Research Leader (number 23XD1423400) (Q. Luo). Data used in the preparation of this article were obtained from the ABCD Study (https://abcdstudy.org), held in the NIMH Data Archive (NDA). This is a multisite, longitudinal study designed to recruit more than 10,000 children aged 9–10 and follow them for over 10 years into early adulthood. The ABCD Study is supported by the National Institutes of Health (NIH) and additional federal partners under award numbers U01DA041048, U01DA050989, U01DA051016, U01DA041022, U01DA051018, U01DA051037, U01DA050987, U01DA041174, U01DA041106, U01DA041117, U01DA041028, U01DA041134, U01DA050988, U01DA051039, U01DA041156, U01DA041025, U01DA041120, U01DA051038, U01DA041148, U01DA041093, U01DA041089, U24DA041123 and U24DA041147. A full list of supporters is available at https://abcdstudy.org/federal-partners.html. A list of participating sites and a complete list of the study investigators can be found at https://abcdstudy.org/consortium_members/. ABCD consortium investigators designed and implemented the study and/or provided data but did not necessarily participate in the analysis or writing of this report. This manuscript reflects the views of the authors and may not reflect the opinions or views of the NIH or ABCD consortium investigators. The ABCD data repository grows and changes over time. The ABCD data used in this report came from the ABCD Study at https://doi.org/10.15154/z563-zd24. This work also received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology; LSHM-CT- 2007-037286), the Horizon 2020-funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders; 695313), Horizon Europe ‘environMENTAL’, grant number 101057429, UK Research and Innovation Horizon Europe funding guarantee (10041392 and 10038599), Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539), the Chinese government via the Ministry of Science and Technology (MOST), the German Center for Mental Health (DZPG), the Bundesministerium für Bildung und Forschung (BMBF grants 01GS08152 and 01EV0711, Forschungsnetz AERIAL 01EE1406A and 01EE1406B and Forschungsnetz IMAC-Mind 01GL1745B), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940, TRR 265 and NE 1383/14-1), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1), the NIH-funded ENIGMA grants (5U54EB020403-05, 1R56AG058854-01 and U54 EB020403), NIH R01DA049238, the NIH, Science Foundation Ireland (16/ERCD/3797) and NSFC grant 82150710554. Further support was provided by grants from the ANR (ANR-12-SAMA-0004 and AAPG2019 – GeBra), the Eranet Neuron (AF12-NEUR0008-01 – WM2NA and ANR-18-NEUR00002-01 – ADORe), the Fondation de France (00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance Publique–Hôpitaux de Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l’Avenir (grant AP-RM-17-013) and the Fédération pour la Recherche sur le Cerveau.
Author information
Authors and Affiliations
Consortia
Contributions
Q. Luo and W.H. had full access to the data. Q. Luo proposed and designed the study. D.Z., L.L., T.B., G.J.B., A.L.W.B., R.B., S.D., H.F., H.G., P.G., A.G., A.H., J.-L.M., M.-L.P.M., E.A., F.N., D.P.O., L.P., M.N.S., S.H., N.V., H.W., R.W. and G.S. acquired the data. W.H. and Q. Luo analyzed the data. W.H. and Q. Luo drafted the paper. L.Y., B.J.S. D.Z., C.L., Z.G., L.C., S.C. and T.B. made critical edits to the paper. All authors contributed to the interpretation of results. All authors contributed to the visualization. All authors read and approved the paper.
Corresponding author
Ethics declarations
Competing interests
S.C. has declared reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH) in relation to lectures delivered for ACAMH, the Canadian AADHD Alliance Resource, the British Association of Psychopharmacology, Healthcare Convention and CCM Group team for educational activity on ADHD, and has received honoraria from Medice. T.B. served in an advisory or consultancy role for Eye Level, Infectopharm, Medice, Neurim Pharmaceuticals, Oberberg GmbH and Takeda. He received conference support or speaker’s fees from Janssen-Cilag, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien and Oxford University Press. The present work is unrelated to the above grants and relationships. L.P. served in an advisory or consultancy role for Roche and Viforpharm and received speaker’s fees from Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors declare no competing interests.
Peer review
Peer review information
Nature Mental Health thanks Valeria Isaac, Sha Tao and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information (download PDF )
Supplementary Figs. 1–5, Methods 1–9, Results 1–7 and Tables 1–17.
Supplementary Data Table 1 (download XLSX )
Differences in environmental, functional, genetic and neuroimaging features among ADHD symptom trajectory subgroups.
Supplementary Data Table 2 (download XLSX )
Biological processes and neurotransmitter systems associated with ADHD symptom trajectories.
Supplementary Data 1 (download XLSX )
Statistical data for Supplementary Figs. 3–5.
Source data
Source Data Fig. 1 (download XLSX )
Statistical data for Fig. 1.
Source Data Fig. 2 (download XLSX )
Statistical data for Fig. 2.
Source Data Fig. 3 (download XLSX )
Statistical data for Fig. 3.
Source Data Fig. 4 (download XLSX )
Statistical data for Fig. 4.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hou, W., Zhu, D., Sahakian, B.J. et al. Cortical thinning and hippocampal expansion as brain signatures of attention deficit hyperactivity disorder symptom trajectories. Nat. Mental Health 4, 263–278 (2026). https://doi.org/10.1038/s44220-025-00578-1
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s44220-025-00578-1


